SL Science Holding Limited (SLBT) Cash Flow Statement
Where SLBT’s cash came from and went, 2025
December 31, 2025 · U.S. dollars- Cash from operations
- −$1.9M −781.7% vs 2024
- Capital expenditures
- $319,685 14.5% of revenue
- Free cash flow
- −$2.2M −101.5% margin
- Returned to shareholders
- —
- Change in cash
- −$2.9M cash at year-end $1.3M
Drawn to scale: where the cash came from and how it was used. Hover for values.
SLBT operating cash flow, capex and free cash flow
SLBT cash flow trends, 2023–2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Operating cash flow | −$2.5M2023 | −$1.9M2025 | — | |
| Capital expenditures | $182,9842023 | $319,6852025 | +32.2%/yr | |
| Free cash flow | −$2.6M2023 | −$2.2M2025 | — | |
| Free cash flow margin | −300.0%2023 | −101.5%2025 | +198.6 pts | |
| Capex / revenue | 20.8%2023 | 14.5%2025 | −6.3 pts |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
SLBT cash flow by activity
SLBT net income vs operating cash flow
Operating cash flow above net income usually means earnings are backed by cash (depreciation and stock-based pay are non-cash expenses).
SLBT cash flow statement
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Operating activities | |||
| Net income | −$3.8M | −$1.2M | $399,035 |
| Depreciation & amortization | $93,685 | $47,247 | $37,191 |
| Change in working capital | $1.7M | $1.3M | −$3.1M |
| Other non-cash items | $155,099 | $159,171 | $173,173 |
| Cash from operating activities | −$1.9M | $280,158 | −$2.5M |
| Investing activities | |||
| Capital expenditures | −$319,685 | −$7,970 | −$182,984 |
| Acquisitions & other investing | $0 | $131,253 | $0 |
| Cash from investing activities | −$319,685 | $123,283 | −$182,984 |
| Financing activities | |||
| Shares issued | $0 | $7.2M | $0 |
| Other financing | −$879,137 | −$4.2M | $2.9M |
| Cash from financing activities | −$879,137 | $3.1M | $2.9M |
| Summary | |||
| Net change in cash | −$2.9M | $3.7M | $216,487 |
| Cash at end of period | $1.3M | $4.1M | $439,354 |
| Free cash flow | −$2.2M | $272,188 | −$2.6M |
| Free cash flow margin | −101.5% | 8.1% | −300.0% |
| Capex / revenue | 14.5% | 0.2% | 20.8% |
| Operating cash flow / net income | — | — | −6.15 |
Negative numbers are cash paid out. Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported; data from EODHD.
SLBT cash generation
In fiscal 2025 (ended December 31, 2025), SL Science generated -$1.9 million of cash from operations (down 781.7%) and spent $0.3 million on capital expenditures, leaving free cash flow of -$2.2 million, −101.5% of revenue. Cash and equivalents fell by $2.9 million over the year.
Related: SLBT income statement, SLBT balance sheet. See the SLBT stock overview for the latest quote and news.
SLBT cash flow FAQ
What is SL Science's free cash flow?
SL Science's free cash flow was -$2.2 million in fiscal 2025: -$1.9 million of operating cash flow minus $0.3 million of capital expenditures It was $0.3 million a year earlier..
How much cash does SL Science generate from operations?
SL Science generated -$1.9 million of cash from operating activities in fiscal 2025.
How much does SL Science spend on capital expenditures?
SL Science spent $0.3 million on capital expenditures in fiscal 2025, 14.5% of revenue, compared with $0.0 million the year before.